PubRank

P G Canonico

Author PubWeight™ 45.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Electron microscopic study on the interaction between normal guinea pig peritoneal macrophages and Coxiella burnetii. Infect Immun 1976 1.65
2 Analytical fractionation of mouse peritoneal macrophages: physical and biochemical properties of subcellular organelles from resident (unstimulated) and cultivated cells. J Reticuloendothel Soc 1978 1.56
3 Phagocytosis of Francisella tularensis by Rhesus monkey peripheral leukocytes. Infect Immun 1975 1.46
4 Lysosomes in skeletal muscle tissue. Zonal centrifugation evidence for multiple cellular sources. J Cell Biol 1970 1.44
5 Purification of large quantities of coxiella burnetii rickettsia by density gradient zonal centrifugation. Appl Microbiol 1972 1.39
6 Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent. Antimicrob Agents Chemother 1983 1.33
7 Pathogenesis of respiratory Klebsiella pneumoniae infection in rats: bacteriological and histological findings and metabolic alterations. Infect Immun 1977 1.29
8 Electron spin resonance studies of spin-labeled mammalian cells by detection of surface-membrane signals. Proc Natl Acad Sci U S A 1973 1.27
9 Fat of Coxiella burnetti in macrophages from immune guinea pigs. Infect Immun 1977 1.16
10 Effects of ribavirin on red blood cells. Toxicol Appl Pharmacol 1984 1.09
11 Tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever. Antiviral Res 1987 1.06
12 Temporal appearance of opsonizing antibody to Francisella tularensis: detection by a radiometabolic assay. Infect Immun 1975 1.05
13 Pathogenesis of tularemia in immune and nonimmune rats. Am J Vet Res 1975 1.04
14 Enhanced efficacy of liposome-encapsulated ribavirin against Rift Valley fever virus infection in mice. Antimicrob Agents Chemother 1985 1.04
15 Relationship of serum beta-glucuronidase and lysozyme to pathogenesis of tularemia in immune and nonimmune rats. Infect Immun 1975 1.01
16 Synthesis and antiviral/antitumor activities of certain 3-deazaguanine nucleosides and nucleotides. J Med Chem 1984 1.01
17 Hematological and bone marrow effects of ribavirin in rhesus monkeys. Toxicol Appl Pharmacol 1984 1.00
18 Induced metabolic sequelae of tularemia in the rat: correlation with tissue damage. Am J Physiol 1975 0.99
19 Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses. Antimicrob Agents Chemother 1984 0.98
20 In-vivo activity of antivirals against exotic RNA viral infections. J Antimicrob Chemother 1984 0.95
21 The use of acridine orange as a lysosomal marker in rat skeletal muscle. J Cell Biol 1969 0.94
22 Antibody response to Rocky Mountain spotted fever. J Clin Microbiol 1976 0.93
23 Effect of ribavirin and tributylribavirin on argentine hemorrhagic fever (Junin virus) in guinea pigs. Antimicrob Agents Chemother 1986 0.92
24 Efficacy, toxicology and clinical applications of ribavirin against virulent RNA viral infections. Antiviral Res 1985 0.90
25 Characterization of monkey peripheral neutrophil granules during infection. Infect Immun 1975 0.82
26 Glucose and alanine metabolism during bacterial infections in rats and rhesus monkeys. Metabolism 1980 0.81
27 Preclinical evaluation of monkeys of a ribavirin regimen proposed for use in Lassa fever patients. Toxicol Appl Pharmacol 1982 0.81
28 Effects of pneumococcal infection on rat liver microsomal enzymes and lipogenesis by isolated hepatocytes. Am J Clin Nutr 1977 0.81
29 Swelling of mitochondria from rabbit liver induced by staphylococcal enterotoxin B. J Infect Dis 1971 0.79
30 Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice. Antimicrob Agents Chemother 1987 0.79
31 Effects of inflammation on peroxisomal enzyme activities, catalase synthesis, and lipid metabolism. Lab Invest 1977 0.78
32 Clofibrate-induced alterations in serum protein patterns. Biochem Pharmacol 1976 0.78
33 Synthesis and biological activity of 5-thiobredinin and certain related 5-substituted imidazole-4-carboxamide ribonucleosides. J Med Chem 1985 0.78
34 Antiviral efficacy of pyrazofurin against selected RNA viruses. Antiviral Res 1982 0.78
35 Peroxisome depletion in rat liver during pneumococcal sepsis. Lab Invest 1975 0.78
36 Subcellular localization of staphylococcal enterotoxin B in rabbit kidney. Am J Physiol 1974 0.78
37 Biochemistry and function of the neutrophil in infected, burned and traumatized hosts. Front Biol 1979 0.78
38 Lysosomal catabolism of a protein toxin: staphylococcal enterotoxin B. Biochim Biophys Acta 1973 0.77
39 Intracellular fate of phase I Coxiella burnetii in guniea pig peritoneal macrophages. J Reticuloendothel Soc 1983 0.77
40 Aminoisobutyric acid transport in primary cultures of normal adult rat hepatocytes. Proc Soc Exp Biol Med 1975 0.77
41 Morphological alterations in blood and bone marrow of ribavirin-treated monkeys. Acta Haematol 1984 0.77
42 Synthesis and antiviral activity of certain carbamoylpyrrolopyrimidine and pyrazolopyrimidine nucleosides. J Med Chem 1982 0.77
43 Protective effect of clofibrate against S. pneumoniae infection in rats. Proc Soc Exp Biol Med 1976 0.76
44 Ranking of prophylactic efficacy of poly(ICLC) against Rift Valley fever virus infection in mice by incremental relative risk of death. Antimicrob Agents Chemother 1987 0.76
45 Inhibition of RNA viruses in vitro and in Rift Valley fever-infected mice by didemnins A and B. Antimicrob Agents Chemother 1982 0.75
46 In vitro studies of interaction of rickettsia and macrophages: effect of ultraviolet light on Coxiella burnetii inactivation and macrophage enzymes. Infect Immun 1980 0.75
47 Elevated glycosyltransferase activities in infected or traumatized hosts: nonspecific response to inflammation. Infect Immun 1980 0.75
48 Lysosomal enzymes in aquatic species. IV. Distribution and particle properties of muscle lysosomes of the lobster, Homarus americanus. Comp Biochem Physiol B 1975 0.75
49 Chemotherapy for 'exotic' RNA viruses. J Antimicrob Chemother 1985 0.75